Reta + Tirz is a composite peptide formulation designed for research applications exploring multi-hormonal metabolic signaling. The blend combines retatrutide, a synthetic tri-agonist peptide active at GLP-1, GIP, and glucagon receptors, with tirzepatide, a dual-agonist peptide targeting GLP-1 and GIP receptors. This formulation allows researchers to examine overlapping and complementary incretin and glucagon-mediated pathways within metabolic systems.
In research and preclinical models, retatrutide is studied for its broad receptor coverage and its influence on appetite signaling, glucose regulation, lipid metabolism, thermogenic pathways, and overall energy expenditure. Tirzepatide contributes an established GLP-1/GIP signaling profile, enabling investigation of enhanced or modified incretin pathway engagement when layered onto a triple-agonist framework.
The Reta + Tirz blend is used in experimental settings to assess receptor interaction dynamics, pathway redundancy, and comparative signaling responses between dual-agonist and tri-agonist metabolic models. Research focus is placed on mechanistic understanding of metabolic regulation and energy utilization rather than therapeutic or clinical application.
